41,471 Shares of Shoulder Innovations, Inc. $SI Bought by CenterBook Partners LP

Posted by Brenda Bartman on Nov 11th, 2026

CenterBook Partners LP acquired a new position in shares of Shoulder Innovations, Inc. (NYSE:SI – Free Report) in the 3rd quarter, HoldingsChannel reports. The firm acquired 41,471 shares of the company’s stock, valued at approximately $784,000.

A number of other institutional investors also recently modified their holdings of the company. China Universal Asset Management Co. Ltd. boosted its holdings in shares of Shoulder Innovations by 28.0% in the 3rd quarter. China Universal Asset Management Co. Ltd. now owns 6,400 shares of the company’s stock worth $120,000 after acquiring an additional 1,400 shares in the last quarter. Compass Financial Management LLC bought a new position in Shoulder Innovations in the 2nd quarter valued at $30,000. Integrated Wealth Concepts LLC acquired a new position in Shoulder Innovations in the second quarter worth $35,000. Bank of America Corp DE boosted its stake in Shoulder Innovations by 43.7% in the first quarter. Bank of America Corp DE now owns 26,983 shares of the company’s stock worth $392,000 after purchasing an additional 8,205 shares in the last quarter. Finally, Bank of New York Mellon Corp acquired a new position in Shoulder Innovations in the first quarter worth $252,000.

Insider Transactions at Shoulder Innovations

In other news, CEO Robert Ball sold 10,175 shares of the business’s stock in a transaction on Monday, September 14th. The stock was sold at an average price of $18.45, for a total transaction of $187,728.75. Following the completion of the sale, the chief executive officer owned 380,824 shares in the company, valued at $7,026,202.80. The trade was a 2.60% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, major shareholder Healthcare Holding B.V. Gilde sold 1,196 shares of the company’s stock in a transaction on Wednesday, August 26th. The shares were sold at an average price of $22.60, for a total value of $27,029.60. Following the transaction, the insider directly owned 2,185,914 shares in the company, valued at $49,401,656.40. This trade represents a 0.05% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold a total of 58,968 shares of company stock worth $1,247,045 over the last 90 days. 29.00% of the stock is owned by insiders.

Shoulder Innovations Trading Up 2.0%

Shares of Shoulder Innovations stock opened at $21.89 on Wednesday. The company has a debt-to-equity ratio of 0.13, a current ratio of 10.68 and a quick ratio of 8.69. The firm has a 50 day simple moving average of $19.03 and a 200 day simple moving average of $17.24. Shoulder Innovations, Inc. has a fifty-two week low of $10.92 and a fifty-two week high of $24.59.

Shoulder Innovations (NYSE:SI – Get Free Report) last posted its quarterly earnings data on Thursday, November 5th. The company reported ($0.34) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.49) by $0.15. The firm had revenue of $16.19 million for the quarter. Shoulder Innovations had a negative return on equity of 25.37% and a negative net margin of 51.72%. On average, analysts anticipate that Shoulder Innovations, Inc. will post -1.70 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of analysts have recently weighed in on SI shares. Weiss Ratings restated a “sell (d)” rating on shares of Shoulder Innovations in a research note on Friday, October 30th. UBS Group upped their price target on shares of Shoulder Innovations from $27.00 to $28.00 and gave the stock a “buy” rating in a research report on Monday, August 10th. Piper Sandler reissued an “overweight” rating and set a $25.00 price objective (up from $19.00) on shares of Shoulder Innovations in a report on Friday, August 7th. Finally, BTIG Research increased their price objective on shares of Shoulder Innovations from $26.00 to $27.00 and gave the stock a “buy” rating in a report on Monday, October 12th. Five investment analysts have rated the stock with a Buy rating and one has given a Sell rating to the company. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $25.75.

Read Our Latest Research Report on SI

Shoulder Innovations Profile

(Free Report)

Shoulder Innovations, Inc. is a medical device company focused on developing and commercializing products for shoulder arthroplasty, or shoulder replacement surgery. The company aims to address challenges associated with conventional shoulder-replacement procedures through implant designs intended to support surgical efficiency, fixation, and patient outcomes. Its product portfolio includes shoulder replacement systems and related components, including glenoid implants and technologies designed for anatomic and reverse shoulder arthroplasty procedures.